Do We Need FDG-PET/CT to Assess Atherosclerosis?

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-016-3568-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evaluating Response to Immunotherapy With 18f-FDG PET/CT: Where Do We Stand?

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2020English

Interim FDG-PET/CT in Hodgkin Lymphoma: What Are We Actually Looking At?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2018English

Cushingoid Facies on 18f-FDG PET/CT

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2014English

RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria Into Daily Practice

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2019English

FDG PET/CT in Carcinoma of Unknown Primary

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2009English

Proposal for a Quantitative 18f-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma

Scientific Reports
Multidisciplinary
2019English

Reporting Guidance for Oncologic 18f-FDG PET/CT Imaging

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

FDG-PET/CT Imaging in Infectious and Inflammatory Disorders

PET Clinics
MedicineNuclear MedicineRadiologyRadiationImaging
2020English

Hypermetabolic Hurthle Cell Adenoma on 18f-FDG PET/CT

Molecular Imaging and Radionuclide Therapy
Nuclear MedicineRadiologyImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy